Note: Ingredients listed on restricted chemical lists
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
>1
EC/CAS
5836-29-3
Name of the chemical
Coumatetralyl (ISO); 4-Hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)cumarin(2016/1179)
Concentration
0,75
General Information
Revision date
2018-11-20
Product name
RACUMIN TRACKING POWDER
supplier name
Bayer (Pty) Ltd
Emergency telephone
+27 (0861) 555 777 (Western Cape Poisons Helpline
Icons in SDS
Company Information
company name
Bayer (Pty) Ltd
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360D, H373, H411
Hazard statements
Code
Statements
H360D
May damage the unborn child
Section 2
2.1 Classification of the substance or mixture
Classification in accordance with Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures, as amended. Reproductive toxicity: Category 1B H360D May damage the unborn child. Specific target organ toxicity - repeated exposure: Category 2 H373 May cause damage to organs (Blood) through prolonged or repeated exposure. Chronic aquatic toxicity: Category 2 H411 Toxic to aquatic life with long lasting effects.
2.2 Label elements
Labelling in accordance with Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures, as amended. Hazard label for supply/use required.
Hazardous Ingredients
Coumatetralyl
Signal word
Danger
Hazard statements
H360D May damage the unborn child. H373 May cause damage to organs (Blood) through prolonged or repeated exposure. H411 Toxic to aquatic life with long lasting effects. EUH401 To avoid risks to human health and the environment, comply with the instructions for use. Restricted to professional users.
Precautionary statements
P201 Obtain special instructions before use. P260 Do not breathe dust. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P311 IF exposed or concerned: Call a POISON CENTER/ doctor/ physician. P501 Dispose of contents/container in accordance with local regulation.
2.3 Other hazards
Because of antivitamin K properties of the active ingredient, absorption can inhibit blood coagulation and cause haemorrhagic syndrome.